Quick Overview
A 2025 Cochrane review pooled 89 trials and 2,905 adults after stroke.
Scientists compared EMS with nothing, sham, or practice, then measured voluntary strength and everyday activity without the machine on. CES beat nothing: moderate strength gain (SMD 0.47, 23 trials, 741 people) and activity gain (SMD 0.50)—high-certainty evidence that lasted after treatment. FES helped activity versus nothing (SMD 0.42) and added a small extra lift versus practice alone (SMD 0.22). Side effects were uncommon.
Teams from Macquarie, Sydney, and Monash published in the Cochrane Library—gold-standard methods.
That is why EMS can help rebuild weak muscle after stroke. Read the full blog for every number, limit, and source.
We always provide direct links to the original research at the end of every article so you can review the evidence yourself.
The Quiet Current Helping Stroke Survivors Rebuild Strength

A 2025 Cochrane review of 89 trials found electrical stimulation can lift muscle strength after stroke.
Muscle weakness after a stroke is brutally common.
It steals walking, reaching, and the simple act of standing up.
Many people never get those skills back in full.
Scientists have asked a plain question for years.
Can a current on the skin help the muscle work again?

A major 2025 Cochrane review now gives a clearer answer.
It looked at electrical stimulation, often called EMS, after stroke.
What the researchers actually tested

They split the treatment into two jobs.
Cyclical electrical stimulation, or CES, aims at weak muscle.
Pads sit on the skin. A small machine makes the muscle contract.
The goal is more voluntary strength — force you can produce without the machine.
Functional electrical stimulation, or FES, is different.
The current fires while you practise a real task.
Walking. Reaching. Standing from a chair.
Both use a current that makes muscle contract.
Typical frequencies sit between 20 and 100 Hz.
Who did the work, and why it carries weight
The review was led by Katharine Scrivener and colleagues.
Teams came from Macquarie University, Monash University, and The University of Sydney.
Australian Catholic University and major Sydney and Melbourne hospitals also took part.
That is not a blogger’s round-up.
It is a Cochrane systematic review.

Cochrane is one of the most trusted names in medical evidence.
The paper was published in the Cochrane Database of Systematic Reviews in 2025.
John Wiley & Sons published it.
The protocol was registered in advance.
Australia has a long record in serious medical science.
These centres sit inside that tradition.
The writers of this post are reporting that paper.
We are not inventing results.
We are translating what the trials measured.
How big was the search?

Reviewers scanned 26,855 records after duplicates were removed.
They read 370 full papers.
They included 89 trials and 2,905 adults after stroke.
Thirty-four trials tested CES in 1,176 people.
Fifty-five trials tested FES in 1,729 people.
Most trials were small. Only nine enrolled more than 50 people.
The latest search ran to December 2024.
The strongest result: strength after CES
Here is the number that matters most.
Twenty-three trials with 741 people compared CES with nothing or a sham.
CES produced a moderate lift in strength.
The pooled effect was an SMD of 0.47.
The 95% confidence interval ran from 0.32 to 0.61.

That finding was rated high-certainty evidence.
Heterogeneity was essentially zero. I² was 0%.
In plain language, the muscle could produce more force without the machine.
That is the point of EMS for weakness.

Twenty of those trials also measured everyday activity.
Reaching. Walking. Standing.
CES produced a moderate lift there too.
SMD 0.50, from 20 trials and 662 people.
Again, high-certainty evidence.
Did the gains last?

Eleven trials followed people after the program stopped.
Mean follow-up was about 10 weeks.
Strength was still better. SMD 0.48. 384 people.
Activity was still better. SMD 0.57. 385 people.
Those later results were moderate-certainty evidence.
The samples were smaller.
The signal did not vanish the day the machine was packed away.
Who seemed to benefit?
The reviewers checked several splits.
Very weak people and merely weak people looked similar.
Subacute stroke and chronic stroke looked similar.
Arm muscles and leg muscles looked similar.

Lower stimulation frequencies, around 30 to 50 Hz, tracked with a slightly larger effect.
Total dose did not show a clean “more minutes always wins” line in the meta-regression.
The bright, honest reading is this.
When weakness is the problem, CES beat doing nothing.
What about FES during practice?

Twelve trials with 235 people compared FES with nothing or sham.
Activity improved by an SMD of 0.42 after the program.
That was moderate-certainty evidence.
Three small trials suggested the activity gain might last.
That later estimate was less certain.
The bigger comparison was FES versus practising the same task without current.
Thirty-five trials. 1,193 people.
The extra benefit was small. SMD 0.22.
That was high-certainty evidence.
People who were more disabled gained a little more from FES than those who were less disabled.
Once someone can already attempt the task, the added current is only a small extra push.
That is not a failure.
It tells therapists when EMS earns its place.
Safety in the trials that reported it

Many studies simply did not list side effects well.
Among those that did, events linked to stimulation were uncommon.
No serious events were described.
Six CES trials with 229 people reported no adverse events.
Ten FES trials with 612 people reported two mild events in one study.
This is not a claim that EMS is risk-free for every person.
It is what this evidence base recorded.
What the review could not settle
Only one small trial compared CES with another strengthening method.
That result was too thin to trust.
Almost no usable data covered community participation or quality of life.
Those questions still need better trials.
This paper does not say EMS replaces physiotherapy.
It does not name a gadget you must buy.
It does not treat stroke itself.
It asks a rehab question.
Can targeted electrical contraction help weak muscle and daily movement?
For CES versus nothing, the answer is yes, with a moderate effect.
Why this blog is standing on solid ground
The source is a Cochrane review, not a single clinic study.
The authors work at major Australian universities and teaching hospitals.
They used GRADE to rate certainty, not vibes.
They pre-registered the protocol.
They separated CES from FES, which many older summaries blurred.
You can check the paper yourself.
Citation: Scrivener K, Ada L, Glinsky JV, Dorsch S, Jamieson S, Brighton-Hall SM, McCredie L, Hanekom A, Lannin NA. Electrical stimulation of the motor system after stroke. Cochrane Database of Systematic Reviews 2025, Issue 12. Art. No.: CD015338.
The practical bright side
If someone has real weakness after stroke, CES has high-certainty support against doing nothing.
The strength gain showed up in activity as well.
Some of that progress was still there after treatment stopped.

That is why more clinics should take this evidence seriously.
Not as a miracle current.
As a measured tool for weak muscle.
EMS will not suit every person or every stage.
A clinician still needs to judge timing, dose, and which muscles to target.
But the old shrug of “we don’t know if it works” is harder to defend.
Eighty-nine trials and 2,905 people have now been put on the table.
The current is quiet.
The data are not.
Featured Product
ORIEMS FIT ULTIMATE KIT 💪 is a 100% Australian award-winning product.
Voted YEAR’S BEST ⭐ for 2024 and 2025.
It is a wide-range targeted muscle stimulator enhanced with EMS technology, designed to support your fitness and relaxation routine. 🌟
Trusted by more than 10,000 happy users with over 450 five-star Google reviews. 😊
Check availability.
Product Disclaimer:
This product is designed only to support fitness and relaxation routines. It is not a medical device and has not been evaluated or registered by the TGA. It is not intended to diagnose, treat, cure or prevent any disease or medical condition. It may not be suitable for everyone. Please consult your doctor or healthcare practitioner before using it.
Like this Research Digest? 📚
Share it with your friends 💬👇
About Our Health Research Digest
We bring you the latest and most important health research papers — simplified and easy to understand.
Each study is broken down into clear, concise summaries and engaging podcasts, with direct links to the original research so you can explore further whenever you like.
We also create content based on your requests. If you’re curious about a specific health topic or would like us to find relevant studies, simplify the findings, and turn them into a podcast, just let us know.
Don’t hesitate to reach out — we’re here to help make health research accessible and useful for you. Contact us anytime.
More EMS Research Scientists Are Studying
1. Can EMS reduce fat?
2. Can EMS increase calorie burn while sitting?
3. Can EMS support muscle toning and muscle gains?
4. Can EMS improve athletic training?
5. Can EMS play a role in muscle loss & frailty?
6. Can EMS reduce pain?
7. EMS vs TENS: What are the differences?
8. Can EMS play a role after stroke?
Research Summary
| Topic | What this review reported |
|---|---|
| Full title | Electrical stimulation of the motor system after stroke |
| Authors | Katharine Scrivener, Louise Ada, Joanne V Glinsky, Simone Dorsch, Serena Jamieson, Sarah M Brighton-Hall, Laura McCredie, Ashleigh Hanekom, Natasha A Lannin |
| Research centres | Macquarie University, Monash University, The University of Sydney, Australian Catholic University, Alfred Health and other Australian rehab centres |
| Publisher | Cochrane Database of Systematic Reviews, 2025, Issue 12, Art. No. CD015338. Published by John Wiley & Sons for The Cochrane Collaboration |
| Date | Review published 15 December 2025. Latest search December 2024 |
| Design | Systematic review and meta-analysis of randomised trials, using Cochrane RoB 1 and GRADE |
| People studied | 2,905 adults after stroke in 89 trials (83 RCTs and 6 randomised cross-over trials) |
| What was tested | CES to build voluntary strength; FES during practice of an everyday activity. Skin electrodes producing a muscle contraction, typically 20–100 Hz |
| How benefit was measured | Strength and the trained activity without the machine on. Participation, quality of life and adverse events were also sought |
| CES vs nothing or sham — strength | Moderate gain immediately after treatment: SMD 0.47 (95% CI 0.32 to 0.61). 23 trials, 741 people. High-certainty evidence |
| CES vs nothing or sham — activity | Moderate gain: SMD 0.50 (95% CI 0.34 to 0.65). 20 trials, 662 people. High-certainty evidence |
| Did CES gains last? | After the program ended, strength SMD 0.48 and activity SMD 0.57. About 11 trials and 384–385 people. Moderate-certainty evidence |
| FES vs nothing or sham | Likely moderate activity gain: SMD 0.42 (95% CI 0.16 to 0.68). 12 trials, 235 people. Moderate-certainty evidence |
| FES vs practice of the same activity | Small extra activity gain: SMD 0.22 (95% CI 0.11 to 0.34). 35 trials, 1,193 people. High-certainty evidence |
| Safety | Related events were uncommon. No serious events were described. Reporting was incomplete |
| Bottom line | CES can be used to increase strength in people with weakness after stroke. Once someone can already practise the task, adding FES gives only a small extra benefit |
| Why it is a strong source | Cochrane methods, pre-registered protocol, GRADE ratings, Australian university and hospital authors. Funding: nil declared |
| Original study | https://doi.org/10.1002/14651858.CD015338.pub2 |
| Cochrane Library page | https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015338.pub2 |
| Free plain-language summary | https://www.cochrane.org/evidence/CD015338_electrical-stimulation-beneficial-improving-strength-and-performance-everyday-activities-after |
Disclaimer
This article is published for general information and educational purposes only. It does not constitute medical advice, health advice, diagnosis, or treatment of any kind.
All content on this website, including any studies, research, or information mentioned, is provided for informational purposes only and does not imply or guarantee any specific health outcomes.
We are not affiliated with, endorsed by, or connected in any way to any researchers, universities, research centres, journals, or institutions referenced in any article. No reference to any study, researcher, or publication should be interpreted as an endorsement or recommendation of any products sold or featured on this website.
Our products (and any products featured or linked in this article) are not intended to diagnose, treat, cure, prevent, or manage any disease or medical condition. Individual results may vary significantly. No guarantees or warranties are made regarding effectiveness, safety, or specific outcomes.
Always consult a qualified healthcare professional before using any product mentioned on this website or making any changes to your health routine, especially if you have a pre-existing medical condition, are pregnant, breastfeeding, have a pacemaker, or are taking medication.
To the fullest extent permitted by law, ORIEMS FIT, its directors, employees, authors, affiliates, and agents disclaim all liability for any loss, damage, cost, expense, or injury (whether direct, indirect, consequential, special, or incidental) arising from the use of, or reliance upon, any information in this article or from the purchase or use of any products featured or sold on this website.
© [ORIEMS FIT] – All Rights Reserved.


